News

Epanova is an ultra-pure mixture of the free fatty acid forms of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The double-blind, multi-center, randomized, placebo-controlled is a 12 week

The patent contains claims regarding beta-alanine compositions in many formulations, wherein the beta-alanine is not part of a dipeptide, polypeptide or oligopeptide and is in the form of

Researchers from Cuba intend to step-up the national production of antineoplastic and complementary drugs, besides making biotechnological products, cubanews.ain.cu reported citing cubadebate.cu. It is estimated that following the

Leonardo technology comprises fully biodegradable, porous silicon particles that can be loaded with a diverse array of secondary nanoparticles such as liposomes, micelles, carbon nanotubes, dendrimers and metallic

University of Calgary’s Hotchkiss Brain Institute will utilize the funds to study the damage that occurs in MS prior to inflammation. To date, central nervous system (CNS) damage

ELND005 is used in the treatment of neuropsychiatric disorders such as Alzheimer’s and bipolar. The company plans to initiate a proof of concept, Phase II study in bipolar

The open-label, multinational, Phase 2 clinical study is designed to assess the safety and tolerability of infusions of GALNS at a dose of 2.0 mg/kg/week over a 52-week

Travelan, an over the counter (OTC) product, is used for the prevention of Travellers Diarrhea, by reducing the risk of infection by ETEC, the most common cause of

Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI), which blocks reverse transcriptase, a key enzyme that is used by the HIV virus to replicate. The marketing authorisation of